James Breen

James Breen

Auto-generated profile, based on publicly available information

James Breen

Quality Milk Management Services Ltd., Cedar Barn, Easton Hill, Easton, Wells, Somerset, BA5 1DU, United Kingdom; School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington Campus, Sutton Bonington, LE12 5RD, United Kingdom

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Journal of Dairy Science
Verified
Journal Article
Open access
JSJ.M. Swinkels
J.M. Swinkels
KLK.A. Leach
K.A. Leach
JBJ.E. Breen
J.E. Breen
BPB. Payne
B. Payne
VWV. White
V. White
ABA.J. Bradley
A.J. Bradley
Selective use of antibiotic dry cow treatment can be implemented at the cow or quarter level, with the latter having the potential to further reduce antibiotic use. Our objective was to compare these 2 approaches in 6 herds in the United Kingdom in which environmental mastitis predominated. Eight hundred seven cows were enrolled and categorized as having a high cell count (n = 401) or low cell count (n = 406) in the last 3 mo of lactation and clinical mastitis history. All quarters of all enrolled cows received an internal teat sealant. Within each category, cows were randomly allocated to 1 of 3 groups; in one group antibiotic treatment was allocated at cow level (i.e., all 4 quarters received antibiotic), whereas in the 2 remaining groups antibiotic treatment was allocated at quarter level, based on California Mastitis Test (CMT) findings. Two different thresholds, score 1 and 2, were used to determine likely infection status. Quarter milk samples were collected at dry off and postcalving for bacteriological culture and somatic cell count (SCC). Cows were monitored for clinical mastitis from dry off until 100 d in milk. Cow level SCC and milk yield data were collated from farm records. Within each category, the 2 quarter level treatment groups were compared with cow level treatment at dry off. Leaving quarters untreated with intramammary antibiotic in cows in the high cell count group, with a CMT <2 or 200,000 cells/mL at dry off.

3 February 2021 in CABI Reviews
Verified
Journal Article
Closed access
JBJames E. Breen
James E. Breen
ABAndrew J. Bradley
Andrew J. Bradley
PDPeter M. Down
Peter M. Down
RHRobert M. Hyde
Robert M. Hyde
KLKatharine A. Leach
Katharine A. Leach
MGMartin J. Green
Martin J. Green
The control of mastitis remains a focus of attention for dairy farmers, veterinary surgeons and advisors due to its impact on cow health and welfare, milk quality, sustainable production, and the financial costs associated with treatment, prevention and ongoing control. In addition, the focus on the unnecessary use of antibiotics in agriculture has meant that mastitis control in dairy herds has received renewed interest, particularly around prevention of new infection and alternative treatment strategies. The latter includes the selective use of intra-mammary antibiotic for infected cows at drying-off, reserving parenteral antibiotic for clinical cases where the cow is ill, and selecting intra-mammary antibiotic treatment for clinical mastitis based on culture results. Treating clinical mastitis caused by Gram-positive pathogens such as Streptococcus spp. with intra-mammary antibiotic remains important to optimise chance of cure and reduce risk of transmission of infection, although antibiotics may not be required for clinical mastitis infections caused by other pathogens, particularly E. coli . The long-term reduction and rationalisation of antibiotic use in mastitis control is achieved through improved management to prevent new infections and avoid the need to treat mastitis. This comes through understanding the predominant epidemiological ‘pattern’ of infection in the herd and targeted implementation of well-specified interventions to reduce the rate of new infection, either in lactation or during the dry period. For most dairy herds, environmental mastitis pathogens predominate and therefore management and hygiene of housed and pastured environments is a key component of mastitis control plans designed to reduce the need to use antibiotics in mastitis control.

2 September 2016 in Livestock
Verified
Journal Article
Closed access
JBJames Breen
James Breen
In herds with confirmed contagious mastitis infection patterns (e.g. characterised by increased and non-seasonal new infection rates in lactation, persistently infected cows from previous lactations, and poor apparent cure rates across the dry period), disease control involves reducing the prevalence of infection and controlling the onward spread of infection to susceptible cows. The latter is particularly important to focus on given the poor chances of cure if treatment is attempted during lactation, and must involve a thorough review of the milking routine, including application of post-milking teat disinfection, segregation, disinfection, biosecurity and possible vaccination strategies if a high prevalence of S. aureus is demonstrated.

2 January 2021 in Livestock
Verified
Journal Article
Closed access
KAKath Aplin
Kath Aplin
JBJames Breen
James Breen
The treatment of clinical mastitis on farm is always under the spotlight for veterinary surgeons due to the financial penalty of withholding milk from the bulk tank, the challenge of achieving a bacteriological cure during lactation compared with during a dry period and the importance of antibiotic use in dairy herds. This article focuses on the management of the FIRST clinical mastitis case in a cow's lactation, as this not only represents the best chance of achieving a bacteriological cure as well as a symptomatic one, but also puts emphasis on the need to measure the outcome of treatment approaches for first cases and the likely origin of first cases so that treatment can be avoided in the future.